Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Jan 06, 2020
Alector Initiates First-in-Human Dosing in Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases
Displaying 21 - 22 of 22